MarketResearch.biz delivers in-depth insights on the global needle-free drug delivery technology market in its upcoming report titled, “Global Needle-Free Drug Delivery Technology Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global needle-free drug delivery technology market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global needle-free drug delivery technology market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global needle-free drug delivery technology market report has been segmented on the basis of technology application, end user and region.
Needle-free drug delivery is an advanced technology used for delivering required drugs or vaccines into patient’s body through a medical device without the need for traditional way of piercing needle. Injections develop various complications in patients such as anxiety, fever, pain, bruising, needle stick injuries, and disgust which leads to avoidance. The advantages of needle-free drug delivery technology over conventional syringes include higher immune coverage, cost-effectiveness, and increased compliance and acceptance by patients. This technology helps expand range of molecules and efficient transdermal delivery of drugs or vaccines of great efficacy. This gave rise to needle-free drug delivery technology and is one of key factors to spur the global needle-free drug delivery technology market. In addition, to reduce healthcare expenditure, adoption of self-administered medications by diabetic patients, awareness about safety from transmitted diseases, to avoid burden of hospital visits.
Needle-free drug delivery devices need to be handled with care otherwise microneedle patches may break and remain under skin. Delivery of drugs with high pressure can damage fragile molecules beneath the skin layer. These are key factors restraining growth of the global needle-free drug delivery technology market. In addition, high-cost involved in R&D of needle-free drug delivery devices and low awareness regarding this technology may hamper growth of this market.
Market in North America dominates the global needle-free drug delivery technology market, followed by Europe. Market in North America is driven by a large pool of patients population and geriatric population. To fulfil this demand for convenient and painless needle-free drug delivery devices led growth of Europe market for needle-free drug delivery devices.
Furthermore, North America is expected to retain its dominance during the forecast period. Asia Pacific is projected to emerge as the fastest rising regional market in the global needle-free drug delivery technology market in the near future owing to increasing prevalence of chronic cardiovascular and neurological diseases, infrastructural development in the medical and healthcare industry, medical tourism, and increasing focus by global key players to spread and strengthen consumer base in this untapped region to meet medical needs are expected to boost the market in Asia Pacific considerably in next few years.
Global Needle-Free Drug Delivery Technology Market Segmentation:
Global Needle-free Drug Delivery Technology Market segmentation by technology:
- Jet Injectors
- Competing Needle-free Technologies
- Novel Needle Technology
- Inhaler Technology
- Transdermal Patch Technology
Global Needle-free Drug Delivery Technology Market segmentation by application:
- Vaccine Delivery
- Pain Management
- Insulin Delivery
- Pediatric Injections
- Other Applications
Global Needle-free Drug Delivery Technology Market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- 3 M
- Antares Pharma Inc.
- Bayer Ag
- Bioject Medical Technologies Inc.
- Glide Pharmaceutical Technologies Ltd.
- InjexPharma Ag
- Johnson & Johnson Inc.
- Medtronic Inc.
- Merck And Co.
- Novartis Ag
- Pancreum LLC
- Pfizer Inc.
- Pharmajet Inc.
- Tandem Diabetes Care Inc.
- Zogenix Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!